Haw Par Corporation Limited (HAWPF)
OTCMKTS · Delayed Price · Currency is USD
10.62
0.00 (0.00%)
Aug 6, 2025, 8:00 PM EDT
MorphoSys AG Market Cap
Haw Par Corporation has a market cap or net worth of $2.43 billion as of August 8, 2025. Its market cap has increased by 43.15% in one year.
Market Cap
2.43B
Enterprise Value
1.88B
Revenue
179.39M
Ranking
n/a
PE Ratio
14.53
Stock Price
$10.62
Market Cap Chart
Since May 8, 1997, Haw Par Corporation's market cap has increased from 413.84M to 2.43B, an increase of 487.26%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 2.43B | 34.38% |
| Dec 31, 2024 | 1.81B | 10.60% |
| Dec 29, 2023 | 1.64B | 3.39% |
| Dec 30, 2022 | 1.58B | -15.10% |
| Dec 31, 2021 | 1.86B | 4.04% |
| Dec 31, 2020 | 1.79B | -14.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Spruce Biosciences | 427.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |